$ERAS leads the live board in Mixed Basket with a Factor Residual Spike

🇺🇸 Erasca $ERAS (Erasca, Inc.) moved into the spotlight today with a unusual relative-strength move that signals a potential rotation within the healthcare biotech space. The move is still stable but thin, with a 42% breadth showing inflow, suggesting some underlying interest rather than broad conviction. This active setup inside the mixed basket indicates that ERAS, a clinical-stage biotech focused on RAS/MAPK-driven cancers, is beginning to attract attention amid a broader rotation in healthcare stocks. The primary confirmation comes from GLBE, which leads the flow and remains the key name to watch. The development around ERAS is part of a broader pattern where healthcare companies - specifically those in biotech and healthcare plans - are showing selective strength. The next step is a second wave of names to confirm the move, which would solidify the narrative of a cautious but developing rotation. For now, traders should watch linked healthcare names, as this could evolve into a more meaningful shift if momentum spreads beyond the initial leaders.